Emergent BioSolutions Inc (EBS) 宣布获得美国战争部一份价值2150万美元的订单,为其供应炭疽疫苗Biothrax,预计交付时间为2026年。该订单进一步巩固了公司在生物防御领域的市场地位。
Emergent BioSolutions Inc (EBS) 宣布获得美国战争部一份价值2150万美元的订单,为其供应炭疽疫苗Biothrax,预计交付时间为2026年。该订单进一步巩固了公司在生物防御领域的市场地位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.